Biotherapeutics Distributor BDI Pharma, Inc. (Formerly known as Blood Diagnostics, Inc.) Unveils Online Ordering Site for Flu Vaccine

COLUMBIA, SC--(Marketwire - May 08, 2009) -

BDI Pharma, Inc. (BDI), the nation’s preeminent distributor of specialty biopharmaceuticals, announced today the unveiling of SecuriFLU (www.securiflu.com), a new online supply solution where customers may pre-book orders for the upcoming flu season, as well as place orders for this year’s current strain. The website also serves to provide education on the impending influenza season along with CDC recommendations and updates on the H1N1 (Swine Flu) virus.

“SecuriFLU provides a simple, convenient supply solution to a healthcare entity’s immediate influenza response needs, as well as accommodates advanced planning for next season’s vaccination clinics,” said Jennifer Jacobson, Vice-President of Corporate Programs for BDI. “By providing our customers with multiple manufacturers’ brands, SecuriFLU and BDI Pharma offer the type of variety necessary to meet the unique requirements of the diverse segments of the U.S. patient population.”

About BDI Pharma, Inc.

Serving the healthcare community since 1995, BDI Pharma, Inc. has built an outstanding reputation as an industry source for products and service. BDI Pharma’s market focus is evident in its commitment to specialty biotherapeutics, chemotherapies, immunologics and hemostatics, including Albumin (Human) USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, as well as hyper-immunes, injectables and physician specialty pharmaceuticals. As a recognized Authorized Distributor of Record for the products it supplies nationwide, BDI Pharma, Inc. services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI Pharma, Inc. defines its customer-centric approach to serving the nation’s healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI Pharma, Inc.'s educational literature and website -- www.bdipharma.com -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.